Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production.

Allam, Gamal

Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production. [electronic resource] - Immunobiology 2007 - 603-12 p. digital

Publication Type: Journal Article

0171-2985

10.1016/j.imbio.2007.05.006 doi


Acute Disease
Alanine Transaminase--metabolism
Animals
Aspartate Aminotransferases--metabolism
Interleukin-10--blood
Interleukin-12--blood
Liver--enzymology
Liver Diseases, Parasitic--drug therapy
Liver Extracts--metabolism
Male
Mice
Schistosoma mansoni--growth & development
Schistosomiasis mansoni--drug therapy
Swine
Tumor Necrosis Factor-alpha--biosynthesis
Vasoactive Intestinal Peptide--pharmacology
Vasodilator Agents--pharmacology
gamma-Glutamyltransferase--metabolism